查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585789

牛结核病诊断市场：按测试、按应用划分 - 2025-2030 年全球预测

Bovine Tuberculosis Diagnosis Market by Tests (Molecular Diagnostic Tests, Serological Tests, Traditional Tests), Application (Point-of-care, Veterinary Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年牛结核病诊断市值为8.2778亿美元，预计到2024年将达到8.8785亿美元，复合年增长率为7.74%，到2030年将达到13.9523亿美元。

牛结核病（bTB）诊断是兽医学的一个重要方面，可确保有效管理和控制这种通用感染疾病。 bTB 诊断的范围包括多种诊断技术，例如皮肤试验、血液检查和分子诊断，每种技术的准确性、成本和实用性水平各不相同。 bTB 诊断主要应用于兽医机构、公共卫生机构和农业部门，其中疾病监测、控制和根除至关重要。最终用途包括兽医院、诊断实验室、农场等。

主要市场统计
基准年[2023] 8.2778亿美元
预测年份 [2024] 88785万美元
预测年份 [2030] 13.9523 亿美元
复合年增长率（%） 7.74%

结核病诊断市场受到结核病发病率增加、诊断技术进步、政府加大疾病控制力度等因素的影响。利用可携式和数位诊断平台等技术进步，开发快速、经济高效且高度准确的诊断工具的机会正在出现。对综合疾病管理系统和即时诊断的需求提供了更多可能性。然而，市场开拓面临先进诊断高成本、监管障碍以及新兴市场认知度低等挑战。透过降低成本和透过技术创新提高意识来解决这些限制将支持市场扩张。

就地检验、生物标记发现和基因检测的创新是最有前途的研究和开发领域。此外，整合人工智慧来简化流程并提高准确性也是一个有前途的途径。市场竞争非常激烈，主要企业都专注于扩大产品系列和地理覆盖范围。为了利用市场机会，相关人员应专注于策略伙伴关係、研发投资以及提高意识的教育宣传活动。优先考虑可提高诊断速度和准确性的经济高效、扩充性的解决方案，可开拓新的细分市场并推动长期成长。

市场动态：快速发展的牛结核病诊断市场的关键市场洞察

牛结核病诊断市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 不断增长的牛中细菌感染的盛行率不断增加
    • 政府大力防治牛结核病
    • 新兴国家的意识不断增强
  • 市场限制因素
    • 测试结果不正确的问题
  • 市场机会
    • 牛结核病诊断解决方案的不断进步
    • 动物消费增加和对安全畜产品的需求不断增长
  • 市场挑战
    • 牛结核病诊断的局限性

波特五力：驾驭牛结核病诊断市场的策略工具

波特的五力架构是了解牛结核病诊断市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对牛结核病诊断市场的外部影响

外部宏观环境因素在塑造牛结核病诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解牛结核病诊断市场的竞争状况

牛结核病诊断市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵牛结核病诊断市场供应商的绩效评估

FPNV 定位矩阵是评估牛结核病诊断市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划牛结核病诊断市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对牛结核病诊断市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 牛数量增加导致细菌感染蔓延
      • 政府为防治牛结核病所做的重要努力
      • 新兴国家的意识不断增强
    • 抑制因素
      • 测试结果不正确的问题
    • 机会
      • 牛结核病诊断解决方案的不断进步
      • 动物消费量增加和对安全动物产品的需求不断增长
    • 任务
      • 与牛结核病诊断相关的局限性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

牛牛结核病诊断市场测试

  • 分子诊断测试
  • 血清学检测
  • 传统测试

第七章牛结核病诊断市场：依应用分类

  • 照护现场
  • 兽医诊所

第八章北美和南美牛结核病诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区牛结核病诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲牛结核病诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AsureQuality Australia Pty Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioMerieux SA
  • Bionote USA Inc.
  • Boehringer Ingelheim GmbH
  • CZ Vaccines SAU
  • Enfer Group
  • F. Hoffmann-La Roche AG
  • IDEXX Laboratories, Inc.
  • Lionex GmbH
  • Pall Corporation
  • PBD Biotech Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Zoetis Inc.
Product Code: MRR-0D217D5AD942

The Bovine Tuberculosis Diagnosis Market was valued at USD 827.78 million in 2023, expected to reach USD 887.85 million in 2024, and is projected to grow at a CAGR of 7.74%, to USD 1,395.23 million by 2030.

Bovine Tuberculosis (bTB) diagnosis is a critical aspect of veterinary healthcare, ensuring effective management and control of this zoonotic disease. The scope of bTB diagnosis encompasses various diagnostic techniques, including skin testing, blood tests, and molecular diagnostics, with each method offering differing levels of accuracy, cost, and practicality. Its necessity lies in preventing the spread of bTB from cattle to humans and other animals, safeguarding both public health and the agricultural economy. bTB diagnostics are applied primarily in veterinary settings, public health institutions, and agricultural sectors where monitoring, controlling, and eradicating the disease are paramount. The end-use scope includes veterinary hospitals, diagnostic laboratories, and farms.

KEY MARKET STATISTICS
Base Year [2023] USD 827.78 million
Estimated Year [2024] USD 887.85 million
Forecast Year [2030] USD 1,395.23 million
CAGR (%) 7.74%

The market for bTB diagnostics is influenced by factors such as increasing incidences of bTB, advancements in diagnostic techniques, and rising governmental initiatives for disease control. Opportunities arise in developing rapid, cost-effective, and highly accurate diagnostic tools, leveraging technological advancements like portable and digital diagnostic platforms. Demand for integrated disease management systems and real-time diagnostics offers further potential. However, market growth faces challenges including the high cost of advanced diagnostics, regulatory hurdles, and limited awareness in developing regions. Addressing these limitations by reducing costs through innovation and increasing awareness can bolster market expansion.

Innovation in point-of-care testing, biomarker discovery, and genetic testing represents the best potential areas for research and development. Additionally, integrating artificial intelligence to streamline and enhance accuracy presents a promising avenue. The market is competitive, with significant players focused on expanding their product portfolios and geographical reach. To capitalize on market opportunities, stakeholders should focus on strategic partnerships, investment in R&D, and education campaigns for awareness. Prioritizing cost-effective, scalable solutions that enhance diagnostic speed and precision can unlock new market segments and drive long-term growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bovine Tuberculosis Diagnosis Market

The Bovine Tuberculosis Diagnosis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of bacterial infections in rising cattle population
    • Significant governmental efforts to combat bovine tuberculosis
    • Increasing awareness in emerging economies
  • Market Restraints
    • Issues relating to inappropriate test results
  • Market Opportunities
    • Ongoing advancements in bovine tuberculosis diagnostic solutions
    • Rising animal consumption and elevated demand for safe animal products
  • Market Challenges
    • Limitations associated with bovine tuberculosis diagnosis

Porter's Five Forces: A Strategic Tool for Navigating the Bovine Tuberculosis Diagnosis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bovine Tuberculosis Diagnosis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bovine Tuberculosis Diagnosis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bovine Tuberculosis Diagnosis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bovine Tuberculosis Diagnosis Market

A detailed market share analysis in the Bovine Tuberculosis Diagnosis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bovine Tuberculosis Diagnosis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bovine Tuberculosis Diagnosis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bovine Tuberculosis Diagnosis Market

A strategic analysis of the Bovine Tuberculosis Diagnosis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bovine Tuberculosis Diagnosis Market, highlighting leading vendors and their innovative profiles. These include AsureQuality Australia Pty Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioMerieux S.A., Bionote USA Inc., Boehringer Ingelheim GmbH, CZ Vaccines S.A.U., Enfer Group, F. Hoffmann-La Roche AG, IDEXX Laboratories, Inc., Lionex GmbH, Pall Corporation, PBD Biotech Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Bovine Tuberculosis Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Tests, market is studied across Molecular Diagnostic Tests, Serological Tests, and Traditional Tests.
  • Based on Application, market is studied across Point-of-care and Veterinary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of bacterial infections in rising cattle population
      • 5.1.1.2. Significant governmental efforts to combat bovine tuberculosis
      • 5.1.1.3. Increasing awareness in emerging economies
    • 5.1.2. Restraints
      • 5.1.2.1. Issues relating to inappropriate test results
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in bovine tuberculosis diagnostic solutions
      • 5.1.3.2. Rising animal consumption and elevated demand for safe animal products
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with bovine tuberculosis diagnosis
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bovine Tuberculosis Diagnosis Market, by Tests

  • 6.1. Introduction
  • 6.2. Molecular Diagnostic Tests
  • 6.3. Serological Tests
  • 6.4. Traditional Tests

7. Bovine Tuberculosis Diagnosis Market, by Application

  • 7.1. Introduction
  • 7.2. Point-of-care
  • 7.3. Veterinary Clinics

8. Americas Bovine Tuberculosis Diagnosis Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Bovine Tuberculosis Diagnosis Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Bovine Tuberculosis Diagnosis Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AsureQuality Australia Pty Ltd.
  • 2. Becton, Dickinson and Company
  • 3. Bio-Rad Laboratories, Inc.
  • 4. BioMerieux S.A.
  • 5. Bionote USA Inc.
  • 6. Boehringer Ingelheim GmbH
  • 7. CZ Vaccines S.A.U.
  • 8. Enfer Group
  • 9. F. Hoffmann-La Roche AG
  • 10. IDEXX Laboratories, Inc.
  • 11. Lionex GmbH
  • 12. Pall Corporation
  • 13. PBD Biotech Ltd.
  • 14. Takara Bio Inc.
  • 15. Thermo Fisher Scientific Inc.
  • 16. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. BOVINE TUBERCULOSIS DIAGNOSIS MARKET RESEARCH PROCESS
  • FIGURE 2. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BOVINE TUBERCULOSIS DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BOVINE TUBERCULOSIS DIAGNOSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. BOVINE TUBERCULOSIS DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023